Withdrawn before it began
A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery
NCT04304079 · Chinese University of Hong Kong · Updated 23 Jan 2024
- What is being tested
- ARssist system
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. The full rules are on the registry page.
- Where
- Hong Kong
- When
- Starts or started 1 Jan 2022, ends 31 May 2024. Registered 11 March 2020.
- Results
- None posted yet.
In the researchers' words
Robotic prostatectomy is a surgery for treating localized prostate cancer. The ARssist system is a novel augmented reality system designed for the assistant surgeon, allowing delivery of augmented reality information via Microsoft HoloLens 2 (a head mount display developed by Microsoft) to better delineate the 3-D operative environment and enable better visualization. To date, there is no prospective study on the clinical performance and utilization of the ARssist system. This study is to evaluate the clinical feasibility and safety of the ARssist system during robotic surgery with the da Vinci Xi system.
Sites
- Prince of Wales HospitalHong Kong, Hong Kong